STAT3 and non-small cell lung carcinoma: We found that gp130 neutralization effectively decreases STAT3 phosphorylation in all seven NSCLC lines regardless of their driver mutation status, suggesting that one or more IL-6 family ligands is responsible for autocrine activation of STAT3 in these cell lines (Fig. 3A).